Benign breast disease (BBD) is a broad category of diagnoses reported to convey a variable degree of increased risk of developing breast cancer. A meta-analysis of the existing literature was performed to quantify the risk estimate associated with BBD. Pubmed, Google Scholar, and EMBASE databases were searched in January 2011. English retrospective and prospective observational studies published from 1972 to 2010 evaluating BBD and the risk of breast cancer were included with data acquisition reported from 1930 to 2007. Eligibility was performed independently following a standardized protocol for full-text publication review by a single reviewer and reviewed by a second author. Of the 3,409 articles retrieved from the literature search, 32 studies met the selection criteria. Reported risk estimates, including relative risk, odds ratio, standardized incidence ratios, rate ratio, hazards ratio, and incidence rate ratio, were the primary outcomes extracted. The most commonly reported pathologies were decided prior to extraction and organized into the following categories for analysis of the extracted risk estimate: non-proliferative disease (NPD), proliferative disease without atypia, benign breast disease not otherwise specified (BBD), and atypical hyperplasia not otherwise specified (AHNOS). The mean age at benign breast biopsy was 46.1 years and the mean age of developing breast cancer was 55.9 years. The mean follow-up length was 12.8 years (range 3.3–20.6). The summary risk estimate of developing breast cancer for NPD was 1.17 (N = 8; 95 % CI 0.94–1.47). Proliferative disease without atypia was associated with significantly increased risk of future breast cancer, summary relative risk 1.76 (N = 15; 95 % CI 1.58–1.95). The summary risk estimate for AHNOS was 3.93 (N = 13; 95 % CI 3.24–4.76). This meta-analysis demonstrates that proliferative benign breast disease with or without atypia is associated with a significant increase in risk of developing breast cancer. These data support management strategies for women with benign breast disease such as additional screening methods or chemoprevention.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Silvera S, Rohan T (2008) Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence. Breast Cancer Res Treat 110:397–409
Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231–273
Lee S, Mohsin SK, Mao S, Hilsenbeck SG, Medina D, Allred DC (2006) Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer. Breast Cancer Res 8:R6
Berryhill GE, Gloviczki JM, Trott JF, Aimo L, Kraft J, Cardiff RD, Paul CT, Petrie WK, Lock AL, Hovey RC (2012) Diet-induced metabolic change induces estrogen-independent allometric mammary growth. Proc Natl Acad Sci USA 109:16294–16299
Su X, Tamimi RM, Collins LC, Baer HJ, Cho E, Sampson L, Willett WC, Schnitt SJ, Connolly JL, Rosner BA, Colditz GA (2010) Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease. Cancer Causes Control 21:1033–1046
Berkey CS, Willett WC, Frazier AL, Rosner B, Tamimi RM, Colditz GA (2011) Prospective study of growth and development in older girls and risk of benign breast disease in young women. Cancer 117:1612–1620
Berkey CS, Willett WC, Frazier AL, Rosner B, Tamimi RM, Rockett HR, Colditz GA (2010) Prospective study of adolescent alcohol consumption and risk of benign breast disease in young women. Pediatrics 125:e1081–e1087
Jung MM, Colditz GA, Collins LC, Schnitt SJ, Connolly JL, Tamimi RM (2011) Lifetime physical activity and the incidence of proliferative benign breast disease. Cancer Causes Control 22:1297–1305
Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Colditz GA (2012) Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics 129:e1192–e1198
Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, Connolly JL, Chen WY, Willett WC, Tamimi RM (2013) Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst 105:1571–1578
Friedenreich C, Bryant H, Alexander F, Hugh J, Danyluk J, Page D (2000) Risk factors for benign proliferative breast disease. Int J Epidemiol 29:637–644
Elmore JG, Gigerenzer G (2005) Benign breast disease—the risks of communicating risk. N Engl J Med 353:297–299
Krieger N, Hiatt RA (1992) Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up. Am J Epidemiol 135:619–631
Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the nurses’ health study. Am J Epidemiol 152:950–964
Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia. Cancer 109:180–187
Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55:2698–2708
Dupont WD, Page DL (1987) Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 125:769–779
Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467–477
Jensen RA, Page DL, Dupont WD, Rogers LW (1989) Invasive breast cancer risk in women with sclerosing adenosis. Cancer 64:1977–1983
Ashbeck EL, Rosenberg RD, Stauber PM, Key CR (2007) Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomark Prev 16:467–472
Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG (1993) Prognostic significance of benign proliferative breast disease. Cancer 71:3896–3907
Boulos FI, Dupont WD, Simpson JF, Schuyler PA, Sanders ME, Freudenthal ME, Page DL (2008) Histologic associations and long-term cancer risk in columnar cell lesions of the breast. Cancer 113:2415–2421
Dorjgochoo T, Deming S, Gao Y-T, Lu W, Zheng Y, Ruan Z, Zheng W, Shu X (2008) History of benign breast disease and risk of breast cancer among women in china: a case–control study. Cancer Causes Control 19:819–828
Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD Jr, Rados MS, Schuyler PA (1994) Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 331:10–15
Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258–1265
Goldacre MJ, Abisgold JD, Yeates DG, Vessey MP (2010) Benign breast disease and subsequent breast cancer: English record linkage studies. J Public Health (Oxf) 32:565–571
Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237
Helmrich SP, Shapiro S, Rosenberg L, Kaufman DW, Slone D, Bain C, Miettinen OS, Stolley PD, Rosenshein NB, Knapp RC, Leavitt T, Schottenfeld D, Engle RL, Levy M (1983) Risk factors for breast cancer. Am J Epidemiol 117:35–45
Hill DA, Preston-Martin S, Ross RK, Bernstein L (2002) Medical radiation, family history of cancer, and benign breast disease in relation to breast cancer risk in young women, USA. Cancer Causes Control 13:711–718
Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B (1980) Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst 65:13–20
Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE (2010) A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control 21:821–828
Levi F, Randimbison L, Te VC, La Vecchia C (1994) Incidence of breast cancer in women with fibroadenoma. Int J Cancer 57:681–683
Lewis JT, Hartmann LC, Vierkant RA, Maloney SD, Shane Pankratz V, Allers TM, Frost MH, Visscher DW (2006) An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 30:665–672
McDivitt RW, Stevensm JA, Lee NC, Wingo PA, Rubin GL, Gersell D (1992) Histologic types of benign breast disease and the risk for breast cancer. Cancer 69:1408–1414
Minami Y, Ohuchi N, Taeda Y, Takano A, Fukao A, Satomi S, Hisamichi S (1999) Risk of breast cancer in Japanese women with benign breast disease. Jpn J Cancer Res 90:600–606
Nomura Y, Tashiro H, Katsuda Y (1993) Benign breast disease as a breast cancer risk in Japanese women. Jpn J Cancer Res 84:938–944
Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361:125–129
Palli D, Turco MRD, Simoncini R, Bianchi S (1991) Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int J Cancer 47:703–706
Sakr R, Rouzier R, Salem C, Antoine M, Chopier J, Darai E, Uzan S (2008) Risk of breast cancer associated with papilloma. Eur J Surg Oncol 34:1304–1308
Shaaban AM, Sloane JP, West CR, Moore FR, Jarvis C, Williams EMI, Foster CS (2002) Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol 26:421–430
Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004) Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 96:616–620
Worsham MJ, Raju U, Lu M, Kapke A, Botttrell A, Cheng J, Shah V, Savera A, Wolman SR (2009) Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat 118:1–7
Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR (2007) Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clin Cancer Res 13:5474–5479
Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M (2001) Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 93:1791–1798
Laird NM, Mosteller F (1990) Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6:5–30
Begg C, Berlin J (1988) Publication bias: a problem in interpreting medical data. J R Stat Soc A 151:419–463
McLaren BK, Schuyler PA, Sanders ME, Jensen RA, Simpson JF, Dupont WD, Page DL (2006) Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer 107:1227–1233
Ghys R (1986) Natural history of benign and malignant breast tumors seen in a screening center. 15-year retrospective study. Cancer 57:1618–1626
Pankratz VS, Hartmann LC, Degnim AC, Vierkant RA, Ghosh K, Vachon CM, Frost MH, Maloney SD, Reynolds C, Boughey JC (2008) Assessment of the accuracy of the gail model in women with atypical hyperplasia. J Clin Oncol 26:5374–5379
Tamimi RM, Rosner B, Colditz GA (2010) Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion. Cancer 116:4944–4953
Khan SA, Rogers MAM, Khurana KK, Meguid MM, Numann PJ (1998) Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 90:37–42
Schnitt SJ (2001) Benign breast disease and breast cancer risk: potential role for antiestrogens. Clin Cancer Res 7:4419s–4422s discussion 4411s–4412s
Tan-Chiu E, Wang J, Costantino JP, Paik S, Butch C, Wickerham DL, Fisher B, Wolmark N (2003) Effects of tamoxifen on benign breast disease in women at high risk for breast cancer. J Natl Cancer Inst 95:302–307
Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG 3rd, Wade JL, Lippman SM (2013) Use of pharmacologic interventions for breast cancer risk reduction: American society of clinical oncology clinical practice guideline. J Clin Oncol 31:2942–2962
Sara W. Dyrstad, MD has full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Conflict of interest
The authors declare that they have no conflict of interest.
NCI P30CA091842, the Breast Cancer Research Foundation, and the Foundation for Barnes-Jewish Hospital. GAC is supported by an ACS Clinical Research Professorship.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Dyrstad, S.W., Yan, Y., Fowler, A.M. et al. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat 149, 569–575 (2015). https://doi.org/10.1007/s10549-014-3254-6
- Benign breast disease
- Breast cancer